D L Carlson Investment Group Inc. Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

D L Carlson Investment Group Inc. decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,421 shares of the medical equipment provider’s stock after selling 544 shares during the quarter. Intuitive Surgical comprises approximately 1.4% of D L Carlson Investment Group Inc.’s portfolio, making the stock its 15th biggest holding. D L Carlson Investment Group Inc.’s holdings in Intuitive Surgical were worth $8,049,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. AIA Group Ltd lifted its stake in shares of Intuitive Surgical by 4.1% in the fourth quarter. AIA Group Ltd now owns 18,533 shares of the medical equipment provider’s stock valued at $9,673,000 after purchasing an additional 722 shares during the period. Hazlett Burt & Watson Inc. increased its holdings in Intuitive Surgical by 87.0% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 677 shares of the medical equipment provider’s stock valued at $352,000 after buying an additional 315 shares in the last quarter. Everstar Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $213,000. O Shaughnessy Asset Management LLC grew its holdings in shares of Intuitive Surgical by 14.1% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 42,537 shares of the medical equipment provider’s stock worth $22,203,000 after acquiring an additional 5,264 shares during the period. Finally, Martin Currie Ltd. increased its stake in Intuitive Surgical by 54.5% in the 4th quarter. Martin Currie Ltd. now owns 3,228 shares of the medical equipment provider’s stock valued at $1,685,000 after purchasing an additional 1,139 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on ISRG shares. Robert W. Baird decreased their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective on the stock. Bernstein Bank raised their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Barclays raised their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $491.84 on Monday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $175.18 billion, a PE ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm has a 50 day moving average price of $556.28 and a 200 day moving average price of $532.97.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.